Gene · 11213
Papers1,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteolysis-targeting chimaeras (PROTACs) as pharmacological tools and therapeutic agents: advances and future challenges. | J Enzyme Inhib Med Chem | 2022 | 35702041 | PubTator, text mining | PubMed |
| Construction of Novel Gene Signature-Based Predictive Model for the Diagnosis of Acute Myocardial Infarction by Combining Random Forest With Artificial Neural Network. | Front Cardiovasc Med | 2022 | 35694667 | PubTator, text mining | PubMed |
| Identification of Immune-Related Genes in Patients with Acute Myocardial Infarction Using Machine Learning Methods. | J Inflamm Res | 2022 | 35692951 | PubTator, text mining | PubMed |
| Progesterone and its receptor signaling in cervical remodeling: Mechanisms of physiological actions and therapeutic implications. | J Steroid Biochem Mol Biol | 2022 | 35690241 | PubTator, text mining | PubMed |
| Oral Cholecalciferol Supplementation in Sahara Black People with Chronic Kidney Disease Modulates Cytokine Storm, Oxidative Stress Damage and Athero-Thromboembolic Risk. | Nutrients | 2022 | 35684085 | PubTator, text mining | PubMed |
| Gene Set Enrichment Analysis Reveals That Fucoidan Induces Type I IFN Pathways in BMDC. | Nutrients | 2022 | 35684042 | PubTator, text mining | PubMed |
| PROTACs: great opportunities for academia and industry (an update from 2020 to 2021). | Signal Transduct Target Ther | 2022 | 35680848 | PubTator, text mining | PubMed |
| Driving role of macrophages in transition from acute kidney injury to chronic kidney disease. | Chin Med J (Engl) | 2022 | 35671177 | PubTator, text mining | PubMed |
| A Pan-Cancer Analysis of IRAK1 Expression and Their Association With Immunotherapy Response. | Front Mol Biosci | 2022 | 35669566 | PubTator, text mining | PubMed |
| The role of Toll-like receptors and neuroinflammation in Parkinson's disease. | J Neuroinflammation | 2022 | 35668422 | PubTator, text mining | PubMed |
| Neuroprotective Effects of Celastrol in Neurodegenerative Diseases-Unscramble Its Major Mechanisms of Action and Targets. | Aging Dis | 2022 | 35656110 | PubTator, text mining | PubMed |
| Genetic and Clinical Characteristics of Patients in the Middle East With Multisystem Inflammatory Syndrome in Children. | JAMA Netw Open | 2022 | 35639375 | PubTator, text mining | PubMed |
| Lung Hyaluronasome: Involvement of Low Molecular Weight Ha (Lmw-Ha) in Innate Immunity. | Biomolecules | 2022 | 35625586 | PubTator, text mining | PubMed |
| Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis. | Front Pharmacol | 2022 | 35620294 | PubTator, text mining | PubMed |
| miR-155-3p: processing by-product or rising star in immunity and cancer? | Open Biol | 2022 | 35611569 | PubTator, text mining | PubMed |
| Recent advances in IAP-based PROTACs (SNIPERs) as potential therapeutic agents. | J Enzyme Inhib Med Chem | 2022 | 35589670 | PubTator, text mining | PubMed |
| HIV-1-induced type I IFNs promote viral latency in macrophages. | J Leukoc Biol | 2022 | 35588262 | PubTator, text mining | PubMed |
| Looking lively: emerging principles of pseudokinase signaling. | Trends Biochem Sci | 2022 | 35585008 | PubTator, text mining | PubMed |
| Targeting IRAK3 for Degradation to Enhance IL-12 Pro-inflammatory Cytokine Production. | ACS Chem Biol | 2022 | 35580266 | PubTator, text mining | PubMed |
| Progresses in epigenetic studies of asthma from the perspective of high-throughput analysis technologies: a narrative review. | Ann Transl Med | 2022 | 35571411 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11213/papers?page=14